Skip to main content
SpringerLink
Log in

Electrochemotherapy

Animal Model Work Review

  • Protocol
Electrochemotherapy, Electrogenetherapy, and Transdermal Drug Delivery

Part of the book series: Methods in Molecular Medicine ((MIMM,volume 37))

Abstract

The major disadvantage of clinically established chemotherapeutic agents is their lack of selectivity for tumor cells. Therefore, for a pronounced antitumor effect, high doses of the chemotherapeutic drugs are needed, which often cause systemic toxicity and severe side effects. Some chemotherapeutic drugs do not exert their antitumor effects because they have hampered transport through the plasma membrane, but once inside the cell, they can be very potent. To overcome membrane restriction, much effort has been put into the development of drug delivery systems. These systems are aimed at facilitating the delivery of a chemotherapeutic drug into tumor cells at concentrations that are sufficient for effective cell killing and, at the same time, to minimize the drug concentration in normal tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Begg, A. C., Deurloo, M. J., Kop, W., and Bartelink, H. (1991) Improvement of ombined modality treatment with cisplatin and radiation using intratumoral drug dministration in murine tumors. Radiother. Oncol. 31, 129–133.

    Article  Google Scholar 

  2. Landrito, J. E., Yoshiga, K., Sakurai, K., and Takada, K. (1994) Effects of ntralesional injection of cisplatin on squamous cell carcinoma and normal tissue f mice. Anticancer Res. 14, 113–118.

    PubMed  CAS  Google Scholar 

  3. De Vita, V. T. Jr., Hellman, S., and Rosenberg, S. A. (1991) Biologic Therapy of Cancer. Lippincott, Philadelphia.

    Google Scholar 

  4. LÃŒbbe, A. S., Bergemann, C., Riess, H., Schriever, F., Reicsardt, P., Possinger, K., Matthias, M., DÃŒrken, B., Herrmann, F., GÃŒrtler, R., Hohenberger, P., Haas, N., Sohr, R., Sander, B., Lemke, A-J., Ohlendorf, D., Huhnht, W., and Huhn, D. (1996) Clinical experience with magnetic drug targeting: A phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res. 56, 4686–4693.

    PubMed  Google Scholar 

  5. Deurloo, M. J., Kop, W., van Tellingen, O., Bartelink, H., and Begg, A. C. (1991) Intratumoral administration of cisplatin in slow-release devices. II. Pharmacokinetics and intratumoral distribution. Cancer Chemother. Pharmacol. 27, 347–353.

    Article  PubMed  CAS  Google Scholar 

  6. Kuang, L., Yang, D. J., Inoue, T., Liu, W. C., Wallace, S., and Wright, K. C. (1996) Percutaneous intratumoral injection of cisplatin microspheres in tumorbearing rats to diminish acute nephrotoxicity. Anti-Cancer Drugs 7, 220–227.

    Article  PubMed  CAS  Google Scholar 

  7. Steerenberg, P. A., Storm, G., De Groot, G., Claessen, A., Bergers, J. J., Franken, M. A. M., van Hoesel Q. G. C. M., Wubs, K. L., and de Jong, W. H. (1988) Liposomes as drug carrier system for cis-diamminedichloroplatinum(II). II: Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution. Cancer Chemother. Pharmacol. 21, 299–307.

    Article  PubMed  CAS  Google Scholar 

  8. Jekunen, A. P., Shalinsky, D. R., Hom, D. K., Albright, K. D., Heath, D., and Howell, S. B. (1993) Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitinin in vitro. Biochem. Pharmacol. 45, 2079–2085.

    Article  PubMed  CAS  Google Scholar 

  9. Mir, L. M., Orlowski, S., Belehradek, J. Jr., Tessie, J., Rols, M. P., Serša, G., Miklavčič, D., Gilbert, R., and Heller, R. (1995) Biomedical application of electric pulses with special emphasis on antitumor electrochemotherapy. Bioelectrochem. Bioenerg. 38, 203–207.

    Article  CAS  Google Scholar 

  10. Neumann, E., Sowers, A. E., and Jordan, C. A., (1989) Electroporation and Electrofusion in Cell Biology. Plenum, New York.

    Google Scholar 

  11. Neumann, E. and Kakorin, S. (1998) Digression of membrane electroporation and electroporative delivery of drugs and genes. Radiol. Oncol. 32, 7–17.

    CAS  Google Scholar 

  12. ČemaÅŸar, M., Jarm, T., Miklavčič, D., Maček-Lebar, A., Ihan, A., Andreja-Kopirat, N., and SerÅ¡a, G. (1998) Effect of electric-field intensity and electropermeabilization and electrosensitivity of various tumor-cell lines in vitro. Electr. Magnetobiol. 17, 263–272.

    Google Scholar 

  13. Orlowski, S. and Mir, L. M. (1993) Cell electropermeabilization: A new tool for biochemical and pharmacological studies. Biochim. Biophys. Acta 1154, 51–63.

    PubMed  CAS  Google Scholar 

  14. Jaroszeski, M. J., Gilbert, R., and Heller, R. (1997) Electrochemotherapy: An emerging drug delivery method for the treatment of cancer. Adv. Drug Deliv. Rev. 26, 185–197.

    Article  PubMed  CAS  Google Scholar 

  15. Poddevin, B., Orlowski, S., Belehradek, J. Jr., and Mir, L. M. (1991) Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem. Pharmacol. 42 (Suppl.), S67–S75.

    Article  PubMed  CAS  Google Scholar 

  16. ČemaÅŸar, M., Miklavčič, D., and SerÅ¡a, G. (1998) Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy. Jpn. J. Cancer Res. 89, 328–333.

    PubMed  Google Scholar 

  17. Melvik, J. E., Pettersen, E. O., Gordon, P. B., and Selgen, P. O. (1986) Increase in cis-diamminedichloroplatinum (II) cytotoxicity upon reversible electroperme-abilization of the plasma membrane in cultured human HNK 3025 cells. Eur. J. Cancer Clin. Oncol. 22, 1523–1530.

    Article  PubMed  CAS  Google Scholar 

  18. SerÅ¡a, G., ČemaÅŸar, M., and Miklavčič, D. (1995) Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res. 55, 3450–3455.

    PubMed  Google Scholar 

  19. Yabushita, H., Yoshikawa, K., Hirata, M., Furuya, H., Jojhoy, T., Fukatsu, H., Noguchi, M., and Nakanishi, M. (1997) Effects of electrochemotherapy on CaSki cells derived from a cervical squamous cell carcinoma. Gynecol. Oncol. 65, 297–303.

    Article  PubMed  CAS  Google Scholar 

  20. Okino, M. and Mohri, H. (1987) Effects of high voltage electrical impulse and an nticancer drug on in vivo growing tumors. Jpn. J. Cancer Res. 78, 1319–1321.

    PubMed  CAS  Google Scholar 

  21. Mir, L. M., Orlowski, S., Belehradek, J. Jr., and Paoletti, C. (1991) Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur. J. Cancer 27, 68–72.

    Article  PubMed  CAS  Google Scholar 

  22. Belehradek, J. Jr., Orlowski, S., Poddevin, B., Paoletti, C., and Mir, L. M. (1991) Electrochemotherapy of spontaneous tumors in mice. Eur. J. Cancer 27, 73–76.

    Article  PubMed  Google Scholar 

  23. Salford, L. G., Persson, B. R. R., Brun, A., Ceberg, C. P., Kongstad, P. Ch., and Mir, L. M. (1993) A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochim. Biophys. Acta 194, 938–943.

    CAS  Google Scholar 

  24. Yamaguchi, O., Irisawa, C., Baba, K., Ogihara, M., Yokota, T., and Shiraiwa, Y. (1994) Potentiation of antitumor effect of bleomycin by local electric pulses in mouse bladder tumor. Tokohu J. Exp. Med. 172, 291–293.

    Article  CAS  Google Scholar 

  25. SerÅ¡a, G., ČemaÅŸar, M., Miklavčič, D., and Mir, L. M. (1994) Electrochemotherapy: variable anti-tumor effect on different tumor models. Bioelectrochem. Bioenerg. 35, 23–27.

    Article  Google Scholar 

  26. Heller, R., Jaroszeski, M., Leo-Messina, J., Perrot, R., Van Voorhis, N., Reintgen, D., and Gilbert, R. (1995) Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy. Bioelectrochem. Bioenerg. 36, 83–87.

    Article  CAS  Google Scholar 

  27. Okino, M., Tomie, H., Kanesada, H., Marumoto, M., Esato, K., and Suzuki, H. (1992) Optimal electric conditions in electrical impulse chemotherapy. Jpn. J. Cancer Res. 83, 1095–1101.

    PubMed  CAS  Google Scholar 

  28. SerÅ¡a, G., ČemaÅŸar, M., Semrov, D., and Miklavčič, D. (1996) Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumors in mice. Bioelectrochem. Bioenerg. 39, 61–66.

    Article  Google Scholar 

  29. Okino, M. and Esato, K. (1990) The effect of single high voltage electrical stimulation with an anticancer drug on in vivo growing malignant tumors. Jpn. J. Surg. 20, 197–204.

    Article  PubMed  CAS  Google Scholar 

  30. Yabushita, H., Yoshikawa, K., Hirata, M., Furuya, H., Hojyoh, T., Fukatsu, H., Noguchi, M., and Nakanishi, M. (1997) Effects of electrochemotherapy on CaSki cells derived from a cervical squamous cell carcinoma. Gynecol. Oncol. 65, 297–303.

    Article  PubMed  CAS  Google Scholar 

  31. Jaroszeski, M. J., Gilbert, R. A., and Heller, R. (1997) In vivo antitumor effect of electrochemotherapy in a hepatoma model. Biochim. Biophys. Acta 1334, 15–18.

    PubMed  CAS  Google Scholar 

  32. Ramirez, L. H., Orlowski, S., An, D., Bindoula, G., Dzodic, R., Ardouin, P., Bognel, C., Belehradek, J. Jr., Munck, J. N., and Mir, L. M. (1998) Electroche-motherapy on liver tumors in rabbits. Br. J. Cancer 77, 2104–2111.

    Article  PubMed  CAS  Google Scholar 

  33. Mir, L. M., Devauchelle, P., Quintin-Colonna, F., Delisie, F., Doliger, S., Fradelizi, D., Belehradek, J. Jr., and Orlowski, S. (1997) First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br. J. Cancer 76, 1617–1622.

    Article  PubMed  CAS  Google Scholar 

  34. Pendas, S., Jaroszeski, M. J., Gilbert, R., Hyacinthe, M., Dang, V., Hickey, J., Pottinger, C., Illingworth, P., and Heller, R. (1998) Direct delivery of chemo therapeutic agents for the treatment of hepatomas and sarcomas in rat models. Radiol. Oncol. 32, 53–64.

    CAS  Google Scholar 

  35. Sersa, G., Miklavcic, D., Cemazar, M., Belehradek, J. Jr., Jarm, T., and Mir, L. M. (1997) Electrochemotherapy with CDDP on LPB sarcoma: Comparison of the anti-tumor effectiveness in immunocompetent and immunodeficient mice. Biolectrochem. Bioenerg. 43, 279–283.

    Article  CAS  Google Scholar 

  36. ČemaÅŸar, M., Miklavčič, D., Ščančar, J., DolÅŸa, V., Golouh, R., and SerÅ¡a, G. (1999) Increased platinum accumulation in SA-1 tumor cells after in vivo electrochemotherapy with cisplatin. Br. J. Cancer 79, 1386–1391.

    Article  PubMed  Google Scholar 

  37. ČemaÅŸar, M., SerÅ¡a, G., and Miklavčič, D. (1998) Electrochemotherapy with cisplatin in treatment of tumor cells resistant to cisplatin. Anticancer Res. 18, 4463–4466.

    PubMed  Google Scholar 

  38. Kanesada, H. (1990) Anticancer effect of high voltage pulses combined with concentration dependent anticancer drugs on Lewis lung carcinoma in vivo. J. Jpn. Soc. Cancer Ther. 25, 2640–2648.

    CAS  Google Scholar 

  39. ČemaÅŸar, M., Miklavčič, D., Vodovnik, L., Jarm, T., Rudolf, Z., Å tabuc, B., Čufer, T., and SerÅ¡a, G. (1995) Improved therapeutic effect of electro-chemotherapy with cisplatin by intratumoral drug administration and changing of electrode orientation for electropermeabilization of EAT tumor model in mice. Radiol. Oncol. 29, 121–127.

    Google Scholar 

  40. Puc, M., Reberšek, S., and Miklavčič, D. (1997) Requirement for a clinical electrochemotherapy device-electroporator. Radiol. Oncol. 31, 368–373.

    Google Scholar 

  41. Hofmann, G A., Dev, S. B., and Nanda, G. S. (1996) Electrochemotherapy: Transition from laboratory to the clinic. IEEE Eng. Med. Biol. Nov/Dec, 124–132.

    Google Scholar 

  42. Gilbert, R. A., Jaroszeski, M. J., and Heller, R. (1997) Novel electrode designs for electrochemotherapy. Biochim. Biophys. Acta 1334, 9–14.

    PubMed  CAS  Google Scholar 

  43. Heller, R., Jaroszeski, M., Perrott, R., Messina, J., and Gilbert, R. (1997) Effective treatment of B16 melanoma by direct delivery of beomycin using electrochemotherapy. Melanoma Res. 7, 10–18.

    Article  PubMed  CAS  Google Scholar 

  44. Jaroszeski, M. J., Gilbert, R., Perrot, R., and Heller, R. (1996) Enhanced effects of multiple treatment electrochemotherapy. Melanoma Res. 6, 427–433.

    Article  PubMed  CAS  Google Scholar 

  45. ČemaÅŸar, M., Milačič, R., Miklavčič, D., Dolzan, V., and SerÅ¡a, G. (1998) Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content. Anticancer Drugs 9, 525–530.

    Article  PubMed  Google Scholar 

  46. Serša, G., Štabuc, B., Čemazar, M., Jančar, B., Miklavčič, D., and Rudolf, Z. (1998) Electrochemotherapy with cisplatin: Potentiation of local cisplatin antitumor effectiveness by application of electric pulses in cancer patients. Eur. J. Cancer 34, 1213–1218.

    Article  PubMed  Google Scholar 

  47. SerÅ¡a, G., Kotnik, V., ČemaÅŸar, M., Miklavčič, D., and Kotnik, A. (1996) Lectrochemotherapy with bleomycin in SA-1 tumor-bearing mice-natural resistance and immune responsiveness. Anticancer Drugs 7, 785–791.

    Article  PubMed  Google Scholar 

  48. Mir, L. M., Orlowski, S., Poddevin, B., and Belehradek, J. Jr. (1992) Lectrochemotherapy tumor treatment is improved by interleukin-2 stimulation of he host’s defenses. Eur. Cytokine Netw. 3, 331–334.

    PubMed  CAS  Google Scholar 

  49. Mir, L. M., Roth, C., Orlowski, S., Belehradek, J. Jr., Fradelizi, D., Paoletti, C., and Kourilsky, P. (1992) Potentiation of antitumoral effect of electrochemo therapy with allogeneic cells producing interleukin-2. C. R. Acad. Sci. Paris 314, 539–544.

    PubMed  CAS  Google Scholar 

  50. Mir, L. M., Roth, C., Orlowski, S., Quintin-Colonna, F., Fradelizi, D., Belehradek, J. Jr., and Kourilsky, P. (1995) Systemic antitumor effect of electrochemotherapy combined with histioincompatible cells secreting interleukin-2. J. Immunother. 7, 30–38.

    Article  Google Scholar 

  51. SerÅ¡a, G., ČemaÅŸar, M., Menart, V., Gaberc-Porekar, V., and Miklavčič, D. (1997) Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-α on SA-1 tumors in mice. Cancer Lett. 116, 85–92.

    Article  PubMed  Google Scholar 

  52. Orlowski, S., An, D., Belehradek, J. Jr., and Mir, L. M. (1998) Antimetastatic effect of electrochemotherapy and histoincompatible interleukin-2-secreting cells in the murine Lewis lung tumor. Anticancer Drugs 9, 551–556.

    Article  PubMed  CAS  Google Scholar 

  53. SerÅ¡a, G., Beravs, K., ČemaÅŸar, M., Miklavčič, D., and DemÅ¡ar, F. (1998) Contrast enhanced MRI assessment of tumor blood volume after application of electric pulses. Electr. Magnetobiol. 17, 299–306.

    Google Scholar 

  54. SerÅ¡a, G., ČemaÅŸar, M., Parkins, C. S., and Chaplin, D. J. (1999) Tumour blood flow changes induced by application of electric pulses. Eur. J. Cancer 35, 672–677.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Tumor Biology, Institute of Oncology, Ljubljana, Slovenia

    Gregor Serša

Authors
  1. Gregor Serša
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of South Florida College of Medicine, USA

    Mark J. Jaroszeski PhD  & Richard Heller PhD  & 

  2. University of South Florida College of Engineering, USA

    Richard Gilbert PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Serša, G. (2000). Electrochemotherapy. In: Jaroszeski, M.J., Heller, R., Gilbert, R. (eds) Electrochemotherapy, Electrogenetherapy, and Transdermal Drug Delivery. Methods in Molecular Medicine, vol 37. Humana Press. https://doi.org/10.1385/1-59259-080-2:119

Download citation

  • DOI: https://doi.org/10.1385/1-59259-080-2:119

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-606-2

  • Online ISBN: 978-1-59259-080-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation